Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
NRXS
)
3.180
UNCHANGED
Streaming Delayed Price
Updated: 2:21 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NRXS
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024
August 09, 2024
Neuraxis just reported results for the second quarter of 2024.
Via
InvestorPlace
NRXS Stock Earnings: Neuraxis Reported Results for Q1 2024
May 22, 2024
Neuraxis just reported results for the first quarter of 2024.
Via
InvestorPlace
NRXS Stock Earnings: Neuraxis Misses Revenue for Q4 2023
April 16, 2024
NRXS stock results show that Neuraxis missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For April 9, 2024
April 09, 2024
Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is projected to report quarterly loss at $0.05 per share on revenue of $198.62 million.
Via
Benzinga
With Only 1.21 Million In The Trading Float, NeurAxis Stock Volatility Exposes An Opportunity, Not A Deterrent ($NRXS)
September 19, 2023
Via
AB Newswire
Exposures
Product Safety
SoftBank-Owned Arm, Instacart File To Go Public
August 27, 2023
Via
Talk Markets
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 12, 2023
Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.
Via
Benzinga
EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome
September 12, 2023
NeurAxis Inc (NYSE: NRXS) announced the publication of a Prospective study evaluating the efficacy of IB-Stim in children featured in the September 2023 Frontiers in Pain Research.
Via
Benzinga
CEO Spotlight: NeurAxis CEO Explains His Better Way Of Treating Pediatric IBS And FAP ($NRXS)
September 06, 2023
Via
AB Newswire
NeurAxis Looks To Revolutionize The Treatment Of Adolescent Stomach Issues
August 30, 2023
NeurAxis, Inc. (NYSEAMERICAN: NRXS) looks to revolutionize how pediatric irritable bowel syndrome (IBS) and functional abdominal pain (FAP) are treated.
Via
Benzinga
EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids
August 29, 2023
NeurAxis Inc (NYSE: NRXS) highlighted A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients with Post-Concussion Syndrome (PCS), a...
Via
Benzinga
NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023
August 15, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
Alcoholic Beverage Marketing Company LQR Debuts On Nasdaq
August 13, 2023
LQR House, which provides digital marketing and branding services to the alcohol industry, went public on Thursday, raising $5 million million in its IPO. Meanwhile NeurAxis, raised $7 million in its...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.
August 11, 2023
Via
ACCESSWIRE
NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin
August 10, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.